House Committee Advances Bill to Add Synthetics to Schedule I of Controlled Substances Act
The House Energy and Commerce Committee on Sept. 21 by unanimous voice vote reported out the Synthetic Drug Control Act of 2015, which would add several synthetic drug compounds to Schedule I of the Controlled Substances Act. The original legislation…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
(H.R. 3537) (here) proposes to add 121 phenylalkylamines, 117 “cannabimimetic agents,” 16 arylcyclohexamines, 26 tryptamines, five benzodiazepines, 13 “opioids and opioid-like substances,” eight piperazines and two tropane alkaloids to Schedule I. Further, the committee by voice vote during markup adopted an amendment to the bill to add 22 more synthetic substances, including 11 more cannabimimetic agents, and three derivatives of fentanyl, to Schedule I. The additions would take effect 30 days after the bill’s enactment. The legislation now goes to the full House for consideration.